ASTRAZENECA PLC

Active Cambridge

Manufacture of basic pharmaceutical products

0 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical productsManufacture of pharmaceutical preparations +2
A

ASTRAZENECA PLC

Manufacture of basic pharmaceutical products

Founded 17 Jun 1992 Active Cambridge, United Kingdom 0 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical productsManufacture of pharmaceutical preparationsWholesale of pharmaceutical goodsResearch and experimental development on biotechnology

Previous Company Names

ZENECA GROUP PLC 16 Feb 1993 — 5 Apr 1999
HACKPLIMCO (NO. FIVE) PUBLIC LIMITED COMPANY 25 Sept 1992 — 16 Feb 1993
ICI BIOSCIENCE PLC 13 Jul 1992 — 25 Sept 1992
HACKPLIMCO (NO.FIVE) PUBLIC LIMITED COMPANY 17 Jun 1992 — 13 Jul 1992
Accounts Submitted 25 Apr 2026 Next due 30 Jun 2026 2 months remaining
Confirmation
Net assets £48,719M £16,141M 2025 year on year
Total assets £114,074M £31,148M 2025 year on year
Total Liabilities £65,355M £15,007M 2025 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom

Website

www.example.com

Full company profile for ASTRAZENECA PLC (02723534), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 17 Jun 1992. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Balance Sheet & P&L (2013–2025)

Cash in Bank

£5741.00M

Increased by £1234.20M (+27%)

Net Assets

£48719.00M

Increased by £16140.77M (+50%)

Total Liabilities

£65355.00M

Increased by £15007.04M (+30%)

Turnover

£59120.00M

Increased by £15768.97M (+36%)

Employees

N/A

Decreased by 94300 (-100%)

Debt Ratio

57%

Decreased by 4 (-7%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 6

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (20)

Blackrock Finance, Inc
6.5%
Wellington Management Group Llp
4.2%

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

ASTRAZENECA PLC Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Apr 2026AuditorsAuditors Resignation Company
27 Apr 2026AuditorsAuditors Resignation Company
25 Apr 2026AccountsAnnual accounts made up to 31 Dec 2025
13 Apr 2026OfficersTermination of Sabera Nazneen Rahman as director on 9 Apr 2026
9 Apr 2026CapitalAllotment of shares (USD 387,745,205.75) on 25 Mar 2026
27 Apr 2026 Auditors

Auditors Resignation Company

27 Apr 2026 Auditors

Auditors Resignation Company

25 Apr 2026 Accounts

Annual accounts made up to 31 Dec 2025

13 Apr 2026 Officers

Termination of Sabera Nazneen Rahman as director on 9 Apr 2026

9 Apr 2026 Capital

Allotment of shares (USD 387,745,205.75) on 25 Mar 2026

Recent Activity

Latest Activity

Auditors Resignation Company

3 days ago on 27 Apr 2026

Auditors Resignation Company

3 days ago on 27 Apr 2026

Annual accounts made up to 31 Dec 2025

5 days ago on 25 Apr 2026

Termination of Sabera Nazneen Rahman as director on 9 Apr 2026

2 weeks ago on 13 Apr 2026

Allotment of shares (USD 387,745,205.75) on 25 Mar 2026

3 weeks ago on 9 Apr 2026